Tag Archives: ip

Regulatory Framework For Follow-On Biologics In Health Care Bill

In the early evening of March 25, 2010, the House voted, finalizing the budget reconciliation package earlier passed by the Senate, that contained some relatively minor amendments to the version of the Senate Bill that the House passed in the … Continue reading

Posted in Follow-On Biologics | Tagged , , , , , , , | 3 Comments

Ariad v. Lilly Comes Down (On Us) – Judge Lourie Rules!

In a majority opinion authored by Judge Lourie for the Federal Circuit sitting en banc (Appeal No. 2008-1248 (Fed. Cir. March 22, 2010)) (a PDF of which is attached to the end of this post), the court held that there … Continue reading

Posted in Written Description Requirements (WDR) | Tagged , , , , , , , , , , | 1 Comment

Happy Belated Birthday to Patents4Life! We are One.

Last Wednesday, Patents4Life forgot to celebrate its first anniversary. I have done a lot of writing, and recruiting of some writers (particular thanks to Paul Cole of Lucas & Co., UK, and Ronald J. Schutz of Robins Kaplan in Minneapolis … Continue reading

Posted in About SLW | Tagged , , , , , , , | Leave a comment

Electronics vs. Biotech – Two Perspectives on “Patent Reform”

The most interesting session I attended today at the AUTM Annual Meeting was one on patent reform. What was most interesting was not a recap of the aspects of S.515, which is the most up-to-date reform bill pending, but the … Continue reading

Posted in Patent Reform Legislation | Tagged , , , , , , , , | Leave a comment